References
1. Arcelay A. Adaptación de un modelo de calidad total a las instituciones sanitarias españolas. Rev Calid Asist. 2000;15:184–92.
2. Rose S, Shah BJ, Onken J, Decross AJ, Davis MH, Jain R, et al. Introducing the Gastroenterologist-Accountable Professionalism in Practice (G-APP) pathway: bridging the G-APP-replacing MOC with a model for lifelong learning and accountability. Gastroenterology. 2015;149(6):1609-26
3. Trujillo-Benavides OE, Navarro-García AM, Baltazar-Montúfar P. Registro de indicadores de calidad de la esófagogastroduodenoscopia en el Hospital de Especialidades del Centro Médico Nacional La Raza del IMSS; Rev Gastroenterol Mex; 2009;74(4): (301-5)]
4. López-Picazo J, Alberca-de-las-Parras F, Sánchez-del Río A et al. Quality indicators in digestive endoscopy: introduction to structure, process, and outcome common indicators. Rev Española Enfermedades Dig [Internet]. 2017;109(6):435–50. Available from: https://online.reed.es/fichaArticulo.aspx?iarf=684760749230-414273194169
5. Sánchez-del-Río A, Pérez-Romero S, López-Picazo J, et al. Indicadores de calidad en colonoscopia. Procedimiento de la colonoscopia. Rev Esp En- ferm Dig 2018;110(5):316-26. DOI: 10.17235/reed.2018.5408/2017
6. Alberca de las Parras F, López Picazo J, Pérez Romero S, Sánchez del Río A, Júdez Gutiérrez J,León Molina J. Indicadores de calidad en colangiopancrea- tografía retrógrada endoscópica. Procedimiento de la colangiopancreatografía retrógrada endoscópica. Rev Esp Enferm Dig 2018;110(10):658-666. DOI: 10.17235/reed.2018.5652/2018
7. Donavedian A. La calidad de la asistencia. ¿Cómo podría ser evaluada? JANO. 1989;864:103–10.
8. Park WG, Shaheen NJ, Cohen J et al. ASGE/ACG Task Force on quality in endoscope. Quality indicators for EGD. Gastrointest Endosc 2015; 81:17-30)
9. Armstrong D, Barkun A, Bridge, R et al. Canadian Association of Gastroenterology consensus guidelines on safety and quality indicators in endoscopy. Canadian Journal of Gastroenterology and Hepatology 2012; 26(1), 17-31.]
10. Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila FI et al. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. Cochrane Database Syst Rev 2010:CD002907
11. Hwang JO, Shergill AK, Acosta RD et al (ASGE standards of practice committee). The role of endoscopy in the management of variceal hemorrhage. Gastrointestinal Endoscopy 2014. 80(2): http://dx.doi.org/10.1016/j.gie.2013.07.023
12. Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007;46:922-3
13. Banerjee S, Shen B, Baron TH, et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2008;67:791-8
14. Fernandez J, Ruiz del Arbol L, Gomez C, et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 2006;131:1049-56
15. Lipp A, Lusardi G. Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy. Cochrane Database Syst Rev 2006:CD005571
16. Jain NK, Larson DE, Schroeder KW, et al. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy: a prospective, randomized, double-blind clinical trial. Ann Intern Med 1987;107:824-8
17. Jain R, Maple JT, Anderson MA et al (ASGE standards of practice committee). The role of endoscopy in enteral feeding Gastrointestinal Endoscopy 2011. 74(1):7-12. doi:10.1016/j.gie.2010.10.021
18. Sreedharan A, Martin J, Leontiadis GI, et al. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev 2010:CD005415
19. de Franchis R, Baveno VF. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53:762-8
20. Wells M, Chande N, Adams P, et al. Meta-analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther 2012;35:1267-78
21. Bisschops R, Areia M, Coron E et al. Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. United European Gastroenterol J. 2016 Oct; 4(5): 629–656
22. Jeon J, Luebeck EG, Moolgavkar SH. Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States). Cancer Causes Control 2006;17:971-81.8
23. Gurudu SR, Ramirez FC. Quality Metrics in Endoscopy. Gastroenterology & Hepatology. 2013;9(4):228-233
24. González-Thompson JL, De la Torre-Bravo A, Abdo Francis JM, Trujillo Benavides OE. Primer Consenso Mexicano sobre Calidad en Endoscopia Gastrointestinal. Asociación Mexicana de Endoscopia Gastrointestinal. Endoscopia 2011;23(4):195-201
25. Teh JL, Tan JR, Lau LJF et al. Longer examination time improves detection of gastric cancer during diagnostic upper gastrointestinal endoscopy.Clin Gastroenterol Hepatol 2015; 13: 480–487.e2
26. Graham DY, Schwartz JT, Cain GD, et al. Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma. Gastroenterology 1982;82:228-31.
27. Evans JA, Chandrasekhara V, Chathadi KV et al. ASGE standards of practice committee. The role of endoscopy in the management of premalignant and malignant conditions of the stomach. Gastrointestinal Endoscopy 2015. 82(1):1-8
28. Dinis-Ribeiro M, Areia M, de Vries AC et al. Management of precancerous conditions and lesions in the stomach (MAPS). Endoscopy 2012; 44: 74–94
29. Evans JA, Early DS, Fukami N et al. ASGE standards of practice committee. The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointestinal Endoscopy 2012. Volume 76, No. 6: 1087-1094
30. Spechler SJ, Sharma P, Souza RF, et al. American Gastroenterological Association technical review on the management of Barrett’s esophagus. Gastroenterology 2011;140:e18-52; quiz e13.
31. Wang KK, Sampliner RE; Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol 2008;103:788-97.
32. Abrams JA, Kapel RC, Lindberg GM, et al. Adherence to biopsy guidelines for Barrett’s esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol 2009;7:736-42; quiz 710.
33. Pais WP, Duerksen DR, Pettigrew NM, et al. How many duodenal biopsy specimens are required to make a diagnosis of celiac disease? Gastrointest Endosc 2008;67:1082-7.
34. Kurien M, Evans KE, Hopper AD, et al. Duodenal bulb biopsies for diagnosing adult celiac disease: Is there an optimal biopsy site? Gastrointest Endosc 2012;75:1190-6.
35. Sharaf, RN, Shergill AK, Odze RD et al, ASGE standards of practice committee. Endoscopic mucosal tissue sampling. Gastrointestinal Endoscopy 2013; 78(2):-224
36. Odze R, Goldblum J, editors. Surgical pathology of the GI tract, liver, biliary tract, and pancreas, 2nd ed. Philadelphia (Pa): Saunders Elsevier,2009
37. Rugge M, Zaninotto G, Parente P, et al. Barrett’s esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA). Ann Surg 2012;256:788-94; discussion 794-5.
38. Sikkema M, Looman CW, Steyerberg EW, et al. Predictors for neoplastic progression in patients with Barrett’s esophagus: a prospective cohort study. Am J Gastroenterol 2011;106:1231-8.
39. Vahabzadeh B, SeetharamAB, CookMB, et al. Validation of the Prague C&M criteria for the endoscopic grading of Barrett’s esophagus by gastroenterology trainees: a multicenter study. Gastrointest Endosc 2012;75:236-41.
40. Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 2006;131:1392-9.
41. Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994;344:1533-6
42. Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol 2012;107:345-60; quiz 361.
43. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013;368:11-21.
44. Hearnshaw SA, Logan RF, Lowe D, et al. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut 2011;60:1327-35.
45. Garcia-Iglesias P, Villoria A, Suarez D, et al. Meta-analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer. Aliment Pharmacol Ther 2011;34:888-900
46. Theivanayagam S, Lim RG, Cobell WJ et al. Administration of erythromycin before endoscopy in upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials. Saudi J Gastroenterol 2013; 19: 205–210
47. Barkun A, Sabbah S, Enns R, et al. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol 2004;99:1238-46.
48. Huang ES, Karsan S, Kanwal F et al. Impact of nasogastric lavage on outcomes in acute GI bleeding. Gastrointest Endosc 2011; 74: 971–980
49. Winstead NS, Wilcox CM. Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage: a cost–effectiveness analysis. Aliment Pharmacol Ther 2007; 26: 1371–1377
50. Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet 1974; 2: 394–397
51. Gralnek I, Dumonceau J-M, Kuipers E et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47:a1–a46
52. Marmo R, Rotondano G, Piscopo R, et al. Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials. Am J Gastroenterol 2007;102:279-89; quiz 469.
53. Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol 2012;107:345-60; quiz 361.
54. Laine L, McQuaid KR. Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol 2009;7:33-47; quiz 1-2
55. Marmo R, Koch M, Cipolletta L, et al. Predicting mortality in nonvariceal upper gastrointestinal bleeders: validation of the Italian PNED score and prospective comparison with the Rockall score. Am J Gastroenterol 2010;105:1284-91.
56. Chiu PW, Ng EK, Cheung FK, et al. Predicting mortality in patients with bleeding peptic ulcers after therapeutic endoscopy.Clin Gastroenterol Hepatol
57. Silvis SE, Farahmand M, Johnson JA, et al. A randomized blinded comparison of omeprazole and ranitidine in the treatment of chronic esophageal stricture secondary to acid peptic esophagitis. Gastrointest Endosc 1996;43:216-21.
58. Jaspersen D, Schwacha H, Schorr W, et al. Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease. J Gastroenterol Hepatol 1996;11:900-22009;7:311-6; quiz 253.
59. Lauritsen K, Rune SJ, Bytzer P, et al. Effect of omeprazole and cimetidine on duodenal ulcer: a double-blind comparative trial. N Engl J Med 1985;312:958-61.
60. Lauritsen K, Rune SJ, Wulff HR, et al. Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial. Gut 1988;29:249-53.
61. Ford AC, Delaney BC, Forman D, et al. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst Rev 2006:CD003840.
62. Banerjee S, Cash BD, Dominitz JA, et al. The role of endoscopy in the management of patients with peptic ulcer disease. Gastrointest Endosc 2010;71:663-8
DOI: 10.17235/reed.2018.5652/2018